EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Antibody‐Based CAR T Cells Produced by Lentiviral Transduction

Sabrina Prommersberger, Michael Hudecek, Thomas Nerreter

Current Protocols in Immunology · 2020-03 · 128 (1)

DOI: 10.1002/cpim.93 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Protocols in Immunology, online erschienen am 04.03.2020. Verfasst von Sabrina Prommersberger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Universitätsklinikum Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Genetic Vectors, Lentivirus, Transduction, Genetic. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bayerische Akademie der Wissenschaften, Horizon 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One promising approach to treat hematologic malignancies is the usage of patient‐derived CAR T cells. There are continuous efforts to improve the function of these cells, to optimize their receptor, and to use them for the treatment of additional types of cancer and especially solid tumors. In this protocol, an easy and reliable approach for CAR T cell generation is described. T cells are first isolated from peripheral blood (here: leukoreduction system chambers) and afterwards activated for one day with anti‐CD3/CD28 Dynabeads. The gene transfer is performed by lentiviral transduction and gene transfer rate can be verified by flowcytometric analysis. Six days after transduction, the stimulatory Dynabeads are removed. T cells are cultured in interleukin‐2 conditioned medium for several days for expansion. There is an option to expand CAR T cells further by co‐incubation with irradiated, antigen‐expressing feeder cell lines. The CAR T cells are ready to use after 10 (without feeder cell expansion) to 24 days (with feeder cell expansion). © 2020 The Authors. Basic Protocol : Generation of CAR T cells by lentiviral transduction

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalGenetic VectorsLentivirusTransduction, GeneticBiomarkersGenetic EngineeringHumansImmunomagnetic SeparationImmunophenotypingImmunotherapy, AdoptiveLymphocyte ActivationReceptors, Antigen, T-CellReceptors, Chimeric AntigenT-Lymphocytes

Stichwörter der Autor:innen

CAR T cellschimeric antigen receptorlentiviral transduction

Substanzen

Antibodies, MonoclonalBiomarkersReceptors, Antigen, T-CellReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • Universitätsklinikum Würzburg, Würzburg, Germany.

Förderung

  • Bayerische Akademie der Wissenschaften
  • Horizon 2020

Zitieren

APA

Prommersberger, S., Hudecek, M., & Nerreter, T. (2020). Antibody‐Based CAR T Cells Produced by Lentiviral Transduction. Current Protocols in Immunology, 128(1). https://doi.org/10.1002/cpim.93

Vancouver

Prommersberger S, Hudecek M, Nerreter T. Antibody‐Based CAR T Cells Produced by Lentiviral Transduction. Current Protocols in Immunology. 2020;128(1). doi:10.1002/cpim.93

BibTeX
@article{Prommersberger2020,
  author = {Prommersberger, Sabrina and Hudecek, Michael and Nerreter, Thomas},
  title = {Antibody‐Based CAR T Cells Produced by Lentiviral Transduction},
  journal = {Current Protocols in Immunology},
  year = {2020},
  volume = {128},
  number = {1},
  doi = {10.1002/cpim.93}
}
Kostenlos starten →